Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima; Akiko Kada; Akihiko Tanizawa; Yuki Yuza; Akihiro Watanabe; Masaki Ito; Hideko Uryu; Katsuyoshi Koh; Chihaya Imai; Nao Yoshida; Yuhki Koga; Naoto Fujita; Akiko M. Saito; Souichi Adachi; Eiichi Ishii; Hiroyuki Shimada

doi:10.1182/blood-2019-122623

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, Akiko Kada, Akihiko Tanizawa, Yuki Yuza, Akihiro Watanabe, Masaki Ito, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M. Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

Faculty of Medical Sciences

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

Original language	English
Number of pages	1
Journal	Blood
Volume	134
Issue number	1
DOIs	https://doi.org/10.1182/blood-2019-122623
Publication status	Published - Nov 13 2019

All Science Journal Classification (ASJC) codes

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2019-122623

Cite this

@article{de9bc9f5dcfd45c5bf8c9c121bd7625c,

title = "Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)",

abstract = "DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.",

author = "Haruko Shima and Akiko Kada and Akihiko Tanizawa and Yuki Yuza and Akihiro Watanabe and Masaki Ito and Hideko Uryu and Katsuyoshi Koh and Chihaya Imai and Nao Yoshida and Yuhki Koga and Naoto Fujita and Saito, {Akiko M.} and Souichi Adachi and Eiichi Ishii and Hiroyuki Shimada",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/blood-2019-122623",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

AU - Shima, Haruko

AU - Kada, Akiko

AU - Tanizawa, Akihiko

AU - Yuza, Yuki

AU - Watanabe, Akihiro

AU - Ito, Masaki

AU - Uryu, Hideko

AU - Koh, Katsuyoshi

AU - Imai, Chihaya

AU - Yoshida, Nao

AU - Koga, Yuhki

AU - Fujita, Naoto

AU - Saito, Akiko M.

AU - Adachi, Souichi

AU - Ishii, Eiichi

AU - Shimada, Hiroyuki

PY - 2019/11/13

Y1 - 2019/11/13

N2 - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

AB - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

UR - http://www.scopus.com/inward/record.url?scp=85074959207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074959207&partnerID=8YFLogxK

U2 - 10.1182/blood-2019-122623

DO - 10.1182/blood-2019-122623

M3 - Article

C2 - 31724002

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

IS - 1

ER -

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this